Tag: GlobeNewswire

NEW YORK, Nov. 02, 2026 (GLOBE NEWSWIRE) — Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“Bright Minds” or the “Company”) announces that the U.S. Food and Drug Administration (“FDA”) has notified the Company via email that its investigational new drug application (“IND”) for Developmental and Epileptic Encephalopathies (“DEEs”) and related Protocol BMB-101-105 has been placed on a partial clinical hold following the FDA’s review.

The proposed trial related to this IND is a randomized, placebo-controlled, double-blind Phase 2 study designed to evaluate the efficacy and safety of ascending doses of BMB-101, up to a maximum tolerated dose, for the treatment of seizures associated with DEEs.

The Company believes that the partial clinical hold covers only the planned Phase 2 trial of BMB-101 in DEE in the United States, and the partial clinical hold does not affect the Company’s other ongoing clinical trials.

The primary reason given by the FDA relates to identified toxicity in mice, and inadequate pharmacokinetic and juvenile toxicity data to support the proposed pediatric enrollment.

The Company believes that the FDA’s observation of toxicity in mice was not seen in any other species. The Company further believes, based on its toxicity reports, peer reviewers, and multiple independent toxicology expert opinions, that the adverse mouse findings were incidental and not drug-related. These are the Company’s beliefs and should not be understood as the FDA findings or as resolving the FDA’s stated concerns.

The Company is awaiting the FDA’s full Partial Clinical Hold Letter. The FDA stated that it would provide the letter within 30 days, including additional details, non-hold recommendations, and study-design recommendations.

Bright Minds intends to immediately request further clarification from the FDA. The Company plans to review the FDA’s Partial Clinical Hold Letter and refine the study in accordance with the FDA’s recommendations with the objective of addressing the identified issues and advancing future U.S. clinical trials. Additional data or studies may be required, and there can be no assurance as to when or whether the partial clinical hold will be lifted or future U.S. trials will be permitted to proceed.

About BMB-101

BMB has completed two clinical trials with BMB-101. To date approximately 90 subjects have received BMB-101 across all the Company’s clinical programs.

Phase 1: In a placebo-controlled single-ascending-dose, multiple-ascending-dose and food-effect studies conducted in 64 healthy volunteers, BMB-101 was well tolerated at all doses tested. There were no serious adverse events, and adverse events were mild and consistent with on-target serotonergic effects. There were no drug-related serious adverse events.

On January 6, 2026, the Company announced the topline data from its Phase 2 BREAKTHROUGH trial. In 24 adults with drug-resistant absence seizures or DEE, most of whom were taking three to five other anti-seizure medications, 79.6% of treatment-emergent adverse events were mild and 17.2% were moderate. No drug-related serious adverse events occurred. Six DEE patients completed the main study treatment with median reduction of motor seizures of 63.3%. All five DEE patients who entered the open label extension remain on therapy with BMB-101.

About Bright Minds

Bright Minds is a biotechnology company developing innovative treatments for patients with neurological and psychiatric disorders. Our pipeline includes novel compounds targeting key receptors in the brain to address conditions with high unmet medical need, including epilepsy, depression, and other CNS disorders. Bright Minds is focused on delivering breakthrough therapies that can transform patients’ lives.

Bright Minds has developed a unique platform of highly selective serotonergic agonists exhibiting selectivity at different serotonergic receptors. This has provided a rich portfolio of NCE programs within neurology and psychiatry.

Contact Information

Investor Relations
Lisa M. Wilson
T: 212-452-2793
E: lwilson@insitecony.com

Alex Vasilkevich
Chief Operating Officer
Bright Minds Biosciences Inc.
T: 414-731-6422
E: alex@brightmindsbio.com
Website: www.brightmindsbio.com

Forward Looking Information

This news release contains “forward-looking information”. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates”, or “believes” or variations (including negative variations) of such words and phrases, or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements in this news release include, without limitation statements concerning the anticipated scope of the partial clinical hold and its expected impact on the Company’s other ongoing clinical trials; receipt and timing of the FDA’s full Partial Clinical Hold Letter, the Company’s intended response and study refinements, potential additional data or studies, whether or when the partial clinical hold may be lifted or future U.S. trials may be permitted to proceed, and the advancement and timing of future U.S. clinical trials. Such statements represent the Company’s current views with respect to future events and are necessarily based upon a number of assumptions and estimates that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political and social risks, contingencies and uncertainties. Many factors, both known and unknown, could cause results, performance, or achievements to be materially different from the results, performance or achievements that are or may be expressed or implied by such forward-looking statements. Material assumptions include that further FDA communications will be consistent with the Company’s current understanding of the scope of the partial clinical hold and its impact on other ongoing clinical trials, that the FDA will provide further feedback as indicated, that an acceptable regulatory path can be identified, and that the Company can obtain the data, funding and other resources necessary to implement any required changes. Actual outcomes may differ materially because of differences between the Company’s current understanding and the FDA’s further communications regarding the scope or impact of the partial clinical hold, the FDA’s assessment of mouse toxicity and pediatric data, additional regulatory requirements, adverse nonclinical or clinical findings, delays in generating data or revising the study, insufficient funding or resources, and the possibility that the partial clinical hold will not be lifted. Additional risk factors can also be found in the Company’s public filings under the Company’s SEDAR+ profile at www.sedarplus.ca. Forward-looking statements contained herein are made as of the date of this news release and the Company disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities legislation. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, the reader is cautioned not to place undue reliance on forward-looking statements.

The Canadian Securities Exchange has neither approved nor disapproved the information contained herein and does not accept responsibility for the adequacy or accuracy of this news release.

NEW YORK, Nov. 02, 2026 (GLOBE NEWSWIRE) — Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“Bright Minds” or the “Company”) announces that the U.S. Food and Drug Administration (“FDA”) has notified the Company via email that its investigational new drug application (“IND”) for Developmental and Epileptic Encephalopathies (“DEEs”) and related Protocol BMB-101-105 has been placed on a partial clinical hold following the FDA’s review.

The proposed trial related to this IND is a randomized, placebo-controlled, double-blind Phase 2 study designed to evaluate the efficacy and safety of ascending doses of BMB-101, up to a maximum tolerated dose, for the treatment of seizures associated with DEEs.

The Company believes that the partial clinical hold covers only the planned Phase 2 trial of BMB-101 in DEE in the United States, and the partial clinical hold does not affect the Company’s other ongoing clinical trials.

The primary reason given by the FDA relates to identified toxicity in mice, and inadequate pharmacokinetic and juvenile toxicity data to support the proposed pediatric enrollment.

The Company believes that the FDA’s observation of toxicity in mice was not seen in any other species. The Company further believes, based on its toxicity reports, peer reviewers, and multiple independent toxicology expert opinions, that the adverse mouse findings were incidental and not drug-related. These are the Company’s beliefs and should not be understood as the FDA findings or as resolving the FDA’s stated concerns.

The Company is awaiting the FDA’s full Partial Clinical Hold Letter. The FDA stated that it would provide the letter within 30 days, including additional details, non-hold recommendations, and study-design recommendations.

Bright Minds intends to immediately request further clarification from the FDA. The Company plans to review the FDA’s Partial Clinical Hold Letter and refine the study in accordance with the FDA’s recommendations with the objective of addressing the identified issues and advancing future U.S. clinical trials. Additional data or studies may be required, and there can be no assurance as to when or whether the partial clinical hold will be lifted or future U.S. trials will be permitted to proceed.

About BMB-101

BMB has completed two clinical trials with BMB-101. To date approximately 90 subjects have received BMB-101 across all the Company’s clinical programs.

Phase 1: In a placebo-controlled single-ascending-dose, multiple-ascending-dose and food-effect studies conducted in 64 healthy volunteers, BMB-101 was well tolerated at all doses tested. There were no serious adverse events, and adverse events were mild and consistent with on-target serotonergic effects. There were no drug-related serious adverse events.

On January 6, 2026, the Company announced the topline data from its Phase 2 BREAKTHROUGH trial. In 24 adults with drug-resistant absence seizures or DEE, most of whom were taking three to five other anti-seizure medications, 79.6% of treatment-emergent adverse events were mild and 17.2% were moderate. No drug-related serious adverse events occurred. Six DEE patients completed the main study treatment with median reduction of motor seizures of 63.3%. All five DEE patients who entered the open label extension remain on therapy with BMB-101.

About Bright Minds

Bright Minds is a biotechnology company developing innovative treatments for patients with neurological and psychiatric disorders. Our pipeline includes novel compounds targeting key receptors in the brain to address conditions with high unmet medical need, including epilepsy, depression, and other CNS disorders. Bright Minds is focused on delivering breakthrough therapies that can transform patients’ lives.

Bright Minds has developed a unique platform of highly selective serotonergic agonists exhibiting selectivity at different serotonergic receptors. This has provided a rich portfolio of NCE programs within neurology and psychiatry.

Contact Information

Investor Relations
Lisa M. Wilson
T: 212-452-2793
E: lwilson@insitecony.com

Alex Vasilkevich
Chief Operating Officer
Bright Minds Biosciences Inc.
T: 414-731-6422
E: alex@brightmindsbio.com
Website: www.brightmindsbio.com

Forward Looking Information

This news release contains “forward-looking information”. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates”, or “believes” or variations (including negative variations) of such words and phrases, or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements in this news release include, without limitation statements concerning the anticipated scope of the partial clinical hold and its expected impact on the Company’s other ongoing clinical trials; receipt and timing of the FDA’s full Partial Clinical Hold Letter, the Company’s intended response and study refinements, potential additional data or studies, whether or when the partial clinical hold may be lifted or future U.S. trials may be permitted to proceed, and the advancement and timing of future U.S. clinical trials. Such statements represent the Company’s current views with respect to future events and are necessarily based upon a number of assumptions and estimates that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political and social risks, contingencies and uncertainties. Many factors, both known and unknown, could cause results, performance, or achievements to be materially different from the results, performance or achievements that are or may be expressed or implied by such forward-looking statements. Material assumptions include that further FDA communications will be consistent with the Company’s current understanding of the scope of the partial clinical hold and its impact on other ongoing clinical trials, that the FDA will provide further feedback as indicated, that an acceptable regulatory path can be identified, and that the Company can obtain the data, funding and other resources necessary to implement any required changes. Actual outcomes may differ materially because of differences between the Company’s current understanding and the FDA’s further communications regarding the scope or impact of the partial clinical hold, the FDA’s assessment of mouse toxicity and pediatric data, additional regulatory requirements, adverse nonclinical or clinical findings, delays in generating data or revising the study, insufficient funding or resources, and the possibility that the partial clinical hold will not be lifted. Additional risk factors can also be found in the Company’s public filings under the Company’s SEDAR+ profile at www.sedarplus.ca. Forward-looking statements contained herein are made as of the date of this news release and the Company disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities legislation. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, the reader is cautioned not to place undue reliance on forward-looking statements.

The Canadian Securities Exchange has neither approved nor disapproved the information contained herein and does not accept responsibility for the adequacy or accuracy of this news release.

Crews mobilized for Foremost’s first drill program on the property, with four areas planned for testing targets based on 2026 gravity survey

VANCOUVER, British Columbia, Nov. 02, 2026 (GLOBE NEWSWIRE) — Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) (“Foremost” or the “Company”) is pleased to announce that it has commenced its first diamond drill program on the Turkey Lake Uranium Project (“Turkey Lake”) in northern Saskatchewan (Figure 1). The program is intended to test priority targets identified by integrating a ground gravity survey completed in January 2026 with historical drilling, electromagnetic, magnetic, and geological data.

Highlights

• Historical uranium intersections highlight the potential of the Turkey Lake property and provide a foundation for additional exploration.
• The property has more than 10 kilometres of underexplored conductive strike length, with priority targets refined by a ground gravity survey completed in January 2026.
• Given the shallow depths (<50 metres of sandstone cover) to most exploration targets on the property, multiple targets can be tested with relatively few metres drilled – a 1,000 metre drill program is planned to test approximately four target areas.

Cameron MacKay, P.Geo., Vice President of Exploration for Foremost, commented: “Turkey Lake is an example of the depth of Foremost’s exploration portfolio. The property has multiple attractive target areas and through our review of historical exploration carried out by Denison and the integration of the new gravity survey completed by Foremost, we have generated several priority targets for drill testing.

The value of the gravity survey is in how it helps us distinguish targets along a long conductive corridor. We prioritized locations where gravity lows coincide with conductors and/or interpreted structural features and then used the historical drilling to provide valuable geological context to plan our specific drill targets. The program is intended to test whether these features reflect alteration and structures capable of hosting uranium mineralization, which could occur both near the shallow unconformity and within the basement.

Given Turkey Lake’s location straddling the margin of the Athabasca Basin, the targets are also relatively shallow, which allows for multiple targets to be tested with relatively few metres of drilling.”

Figure 1. Turkey Lake regional setting and location.

Historical work provides a foundation for the next steps

Turkey Lake is located along the northeastern margin of Saskatchewan’s Athabasca Basin, approximately 23 kilometres north of the McClean Lake Mill and 25 kilometres north of the Eagle Point Mine (Figure 1). Historical drilling, geophysical and geochemical surveys provide a foundation for refining and testing targets at Turkey Lake.

Previous drilling identified uranium mineralization, including:

• 0.16% U₃O₈ over 0.6 metres in hole TUR-4ⁱ immediately above the sub-Athabasca unconformity;
• 0.12% U₃O₈ over 0.5 metres in hole TL-10-13ⁱⁱ; and
• Elevated radioactivity in nearby follow-up drilling, providing additional indications of uranium potential along the conductive corridor.

The 2026 gravity survey builds on this work, helping prioritize targets along the broader corridor.

The historical drilling results referred to in this news release are derived from public assessment files filed with the Government of Saskatchewan. The Qualified Person has not independently verified these historical results, and they should not be relied upon as indicative of the grade or extent of mineralization on the property.

A shallow setting with room for further exploration

The property straddles the edge of the Athabasca Basin, meaning it spans both sandstone-covered ground and exposed basement terrain outside the Basin’s margin (Figure 2). Where sandstone is present, its thickness is less than 50 metres, placing the sandstone–basement contact, or unconformity, at shallow depths. The unconformity is a common target for uranium mineralization.

More than 10 kilometres of underexplored conductive strike length (Figure 2) provides scope to test for both unconformity-related and basement-hosted uranium mineralization. Historical uranium intersections establish an exploration starting point, while the new gravity data help prioritize where to test within the broader corridor.

Figure 2. Turkey Lake compilation map

New gravity data sharpen targets along an underexplored corridor

The ground gravity survey completed in January 2026 identified multiple gravity low anomalies. These are interpreted as possible zones of hydrothermal alteration and potential fluid pathways. Several coincide with electromagnetic conductors and magnetic features, allowing the Company to focus drilling on locations where multiple geological features and datasets point to the existence of a common geological target (Figure 2).  

The top targets generated from the gravity survey have been grouped into (i) those situated along the edge of the Athabasca Basin with the potential for unconformity-hosted mineralization (“Basin Edge Targets”) and (ii) those outside of the Basin, which lack sandstone cover and thus represent targets for basement-hosted mineralization (“BEX Targets”).

Qualified Person

The technical content of this news release has been reviewed and approved by Cameron MacKay, P.Geo., Vice President of Exploration for Foremost Clean Energy Ltd., and a Qualified Person under National Instrument 43-101.

About Foremost

Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) (WKN: A3DCC8) is a North American uranium, lithium, and gold exploration company strategically positioned to support the long-term growth in demand expected for reliable, carbon-free energy sources.

The Company has a portfolio of 10 property interests spanning over 330,000 acres in the prolific, uranium-rich Athabasca Basin region of northern Saskatchewan. Upon completion of the transaction announced on October 22, 2026, Foremost will hold an option from Denison Mines Corp. (“Denison”) (NYSE American: DNN) (TSX: DML) to increase its interest to up to 70% in eight prospective uranium properties (other than Hatchet Lake, in which Foremost can earn up to 51%), and a minority (20%) ownership interest in the GR and Blackwing joint ventures with Denison.

The Company’s uranium exploration efforts benefit from access to extensive historic drilling and geophysical data for targeting high-potential, mineralized trends. To date, Foremost has completed geophysical surveys and multiple drill campaigns that have generated encouraging results and defined high-priority exploration targets for follow-up drilling.

Foremost also has a portfolio of lithium-focused projects at varying stages of development spanning 43,000+ acres in Manitoba, providing exposure to other critical materials essential in electrification and energy storage.

For further information, please visit the Company’s website at www.foremostcleanenergy.com.

Contact and Information

David Cates, Interim CEO
info@foremostcleanenergy.com

Investor Relations

Dave Gentry
RedChip Companies, Inc.
1-407-644-4256
1-800-REDCHIP (733-2447)
FMST@redchip.com

Follow us or contact us on social media:

X: @fmstcleanenergy
LinkedIn: https://www.linkedin.com/company/foremostcleanenergy
Facebook: https://www.facebook.com/ForemostCleanEnergy

Forward-Looking Statements

Except for the statements of historical fact contained herein, the information presented in this news release and oral statements made from time to time by representatives of the Company are or may constitute “forward-looking statements” as such term is used in applicable United States and Canadian laws and including, without limitation, within the meaning of the Private Securities Litigation Reform Act of 1995, for which the Company claims the protection of the safe harbor for forward-looking statements. These statements relate to analyses and other information that are based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management. Any other statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, using words or phrases such as “expects” or “does not expect,” “is expected,” “anticipates” or “does not anticipate,” “plans,” “estimates” or “intends,” or stating that certain actions, events or results “may,” “could,” “would,” “might” or “will” be taken, occur or be achieved) are not statements of historical fact and should be viewed as forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.

Such forward-looking statements include, among others, statements with respect to: the scope, timing and objectives of the drill program at Turkey Lake, including the planned 1,000 metres of drilling and the number of target areas expected to be tested; the potential of Turkey Lake to host unconformity-related or basement-hosted uranium mineralization; the interpretation of historical drilling, geophysical, geochemical and geological data, including the significance of historical uranium intersections as a foundation for additional exploration; the interpretation of gravity low anomalies as possible zones of hydrothermal alteration and potential fluid pathways, and the prioritization of drill targets based on such interpretation; the expectation that the shallow depth of sandstone cover will allow multiple targets to be tested with relatively few metres of drilling; the potential for further exploration along the conductive corridor at Turkey Lake; the completion of the transaction with Denison announced on October 22, 2026 and the Company’s ability to increase its interest in the properties under option from Denison; and the long-term growth in demand expected for carbon-free energy sources.

In making the forward-looking statements in this news release, the Company has applied several material assumptions, including, without limitation, that: the Company’s interpretation of historical drilling, geophysical, geochemical and geological data, including the data from the ground gravity survey completed in January 2026, is accurate; historical drilling results and other historical data are reliable and indicative of the potential for uranium mineralization at Turkey Lake; the drill program will be carried out as planned, within the anticipated budget and timeframe, and will test the targets currently identified; drilling equipment, contractors, supplies and qualified personnel will be available as required; the transaction with Denison will be completed on the terms and within the timeframes currently anticipated; the Company will have access to sufficient capital, on acceptable terms, to fund its exploration programs and to satisfy the requirements to increase its interest in the properties under option from Denison; all required permits and approvals will be obtained, and any required consultation with Indigenous communities will be completed, in a timely manner; there will be no material adverse change in uranium prices, general economic, market or industry conditions; and exploration and permitting activities will not be materially delayed by weather, regulatory or other factors.

Forward-looking information is subject to certain risks, trends and uncertainties that could cause actual results to differ materially from those projected. Many of these factors are beyond the Company’s ability to control or predict. Important factors that may cause actual results to differ materially and that could impact the Company and the statements contained in this news release include, among others: the inherent uncertainty of mineral exploration and the speculative nature of exploration-stage properties; the risk that the drill program does not intersect uranium mineralization or that exploration does not result in the discovery or delineation of a mineral resource; the risk that historical drilling results and other historical data are inaccurate, incomplete or not indicative of mineralization at Turkey Lake; uncertainties in the interpretation of geological and geophysical data, including the risk that gravity low anomalies do not reflect hydrothermal alteration or structures capable of hosting uranium mineralization; the risk that the drill program is delayed, reduced in scope or does not test the planned number of targets; the availability of drilling equipment, contractors, supplies and qualified personnel; the risk that the transaction with Denison is not completed on the anticipated terms or timeline, or at all; the Company’s inability to complete the expenditures and other requirements to increase its interest in the properties under option from Denison; the availability of capital to fund programs and the resulting dilution caused by the raising of capital through the sale of shares; continuity of agreements with third parties, including Denison; fluctuations in uranium and other commodity prices and in the market price of the Company’s common shares; risks and uncertainties associated with the environment; and delays in obtaining governmental approvals, permits or financing.

Additional factors that may cause actual results to differ materially and that could impact the Company and the statements contained in this news release can be found in the Company’s filings with the Securities and Exchange Commission. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Although the Company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, it can give no assurance that its expectations will be achieved. The Company assumes no obligation to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Accordingly, readers should not place undue reliance on forward-looking statements contained in this news release and in any document referred to in this news release. This news release shall not constitute an offer to sell or the solicitation of an offer to buy securities. Please refer to the Company’s most recent filings under its profile on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov for further information respecting the risks affecting the Company and its business.

The CSE has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.

^{__________________________
i} Saskatchewan Mineral Assessment File 64L05-0037
ⁱⁱ Saskatchewan Mineral Assessment File 64L12-0077

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/2b9204aa-9323-4a54-b77a-bc290813bd57

https://www.globenewswire.com/NewsRoom/AttachmentNg/c9407021-6c63-4e0f-96de-85529060a703

Crews mobilized for Foremost’s first drill program on the property, with four areas planned for testing targets based on 2026 gravity survey

VANCOUVER, British Columbia, Nov. 02, 2026 (GLOBE NEWSWIRE) — Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) (“Foremost” or the “Company”) is pleased to announce that it has commenced its first diamond drill program on the Turkey Lake Uranium Project (“Turkey Lake”) in northern Saskatchewan (Figure 1). The program is intended to test priority targets identified by integrating a ground gravity survey completed in January 2026 with historical drilling, electromagnetic, magnetic, and geological data.

Highlights

• Historical uranium intersections highlight the potential of the Turkey Lake property and provide a foundation for additional exploration.
• The property has more than 10 kilometres of underexplored conductive strike length, with priority targets refined by a ground gravity survey completed in January 2026.
• Given the shallow depths (<50 metres of sandstone cover) to most exploration targets on the property, multiple targets can be tested with relatively few metres drilled – a 1,000 metre drill program is planned to test approximately four target areas.

Cameron MacKay, P.Geo., Vice President of Exploration for Foremost, commented: “Turkey Lake is an example of the depth of Foremost’s exploration portfolio. The property has multiple attractive target areas and through our review of historical exploration carried out by Denison and the integration of the new gravity survey completed by Foremost, we have generated several priority targets for drill testing.

The value of the gravity survey is in how it helps us distinguish targets along a long conductive corridor. We prioritized locations where gravity lows coincide with conductors and/or interpreted structural features and then used the historical drilling to provide valuable geological context to plan our specific drill targets. The program is intended to test whether these features reflect alteration and structures capable of hosting uranium mineralization, which could occur both near the shallow unconformity and within the basement.

Given Turkey Lake’s location straddling the margin of the Athabasca Basin, the targets are also relatively shallow, which allows for multiple targets to be tested with relatively few metres of drilling.”

Figure 1. Turkey Lake regional setting and location.

Historical work provides a foundation for the next steps

Turkey Lake is located along the northeastern margin of Saskatchewan’s Athabasca Basin, approximately 23 kilometres north of the McClean Lake Mill and 25 kilometres north of the Eagle Point Mine (Figure 1). Historical drilling, geophysical and geochemical surveys provide a foundation for refining and testing targets at Turkey Lake.

Previous drilling identified uranium mineralization, including:

• 0.16% U₃O₈ over 0.6 metres in hole TUR-4ⁱ immediately above the sub-Athabasca unconformity;
• 0.12% U₃O₈ over 0.5 metres in hole TL-10-13ⁱⁱ; and
• Elevated radioactivity in nearby follow-up drilling, providing additional indications of uranium potential along the conductive corridor.

The 2026 gravity survey builds on this work, helping prioritize targets along the broader corridor.

The historical drilling results referred to in this news release are derived from public assessment files filed with the Government of Saskatchewan. The Qualified Person has not independently verified these historical results, and they should not be relied upon as indicative of the grade or extent of mineralization on the property.

A shallow setting with room for further exploration

The property straddles the edge of the Athabasca Basin, meaning it spans both sandstone-covered ground and exposed basement terrain outside the Basin’s margin (Figure 2). Where sandstone is present, its thickness is less than 50 metres, placing the sandstone–basement contact, or unconformity, at shallow depths. The unconformity is a common target for uranium mineralization.

More than 10 kilometres of underexplored conductive strike length (Figure 2) provides scope to test for both unconformity-related and basement-hosted uranium mineralization. Historical uranium intersections establish an exploration starting point, while the new gravity data help prioritize where to test within the broader corridor.

Figure 2. Turkey Lake compilation map

New gravity data sharpen targets along an underexplored corridor

The ground gravity survey completed in January 2026 identified multiple gravity low anomalies. These are interpreted as possible zones of hydrothermal alteration and potential fluid pathways. Several coincide with electromagnetic conductors and magnetic features, allowing the Company to focus drilling on locations where multiple geological features and datasets point to the existence of a common geological target (Figure 2).  

The top targets generated from the gravity survey have been grouped into (i) those situated along the edge of the Athabasca Basin with the potential for unconformity-hosted mineralization (“Basin Edge Targets”) and (ii) those outside of the Basin, which lack sandstone cover and thus represent targets for basement-hosted mineralization (“BEX Targets”).

Qualified Person

The technical content of this news release has been reviewed and approved by Cameron MacKay, P.Geo., Vice President of Exploration for Foremost Clean Energy Ltd., and a Qualified Person under National Instrument 43-101.

About Foremost

Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) (WKN: A3DCC8) is a North American uranium, lithium, and gold exploration company strategically positioned to support the long-term growth in demand expected for reliable, carbon-free energy sources.

The Company has a portfolio of 10 property interests spanning over 330,000 acres in the prolific, uranium-rich Athabasca Basin region of northern Saskatchewan. Upon completion of the transaction announced on October 22, 2026, Foremost will hold an option from Denison Mines Corp. (“Denison”) (NYSE American: DNN) (TSX: DML) to increase its interest to up to 70% in eight prospective uranium properties (other than Hatchet Lake, in which Foremost can earn up to 51%), and a minority (20%) ownership interest in the GR and Blackwing joint ventures with Denison.

The Company’s uranium exploration efforts benefit from access to extensive historic drilling and geophysical data for targeting high-potential, mineralized trends. To date, Foremost has completed geophysical surveys and multiple drill campaigns that have generated encouraging results and defined high-priority exploration targets for follow-up drilling.

Foremost also has a portfolio of lithium-focused projects at varying stages of development spanning 43,000+ acres in Manitoba, providing exposure to other critical materials essential in electrification and energy storage.

For further information, please visit the Company’s website at www.foremostcleanenergy.com.

Contact and Information

David Cates, Interim CEO
info@foremostcleanenergy.com

Investor Relations

Dave Gentry
RedChip Companies, Inc.
1-407-644-4256
1-800-REDCHIP (733-2447)
FMST@redchip.com

Follow us or contact us on social media:

X: @fmstcleanenergy
LinkedIn: https://www.linkedin.com/company/foremostcleanenergy
Facebook: https://www.facebook.com/ForemostCleanEnergy

Forward-Looking Statements

Except for the statements of historical fact contained herein, the information presented in this news release and oral statements made from time to time by representatives of the Company are or may constitute “forward-looking statements” as such term is used in applicable United States and Canadian laws and including, without limitation, within the meaning of the Private Securities Litigation Reform Act of 1995, for which the Company claims the protection of the safe harbor for forward-looking statements. These statements relate to analyses and other information that are based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management. Any other statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, using words or phrases such as “expects” or “does not expect,” “is expected,” “anticipates” or “does not anticipate,” “plans,” “estimates” or “intends,” or stating that certain actions, events or results “may,” “could,” “would,” “might” or “will” be taken, occur or be achieved) are not statements of historical fact and should be viewed as forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.

Such forward-looking statements include, among others, statements with respect to: the scope, timing and objectives of the drill program at Turkey Lake, including the planned 1,000 metres of drilling and the number of target areas expected to be tested; the potential of Turkey Lake to host unconformity-related or basement-hosted uranium mineralization; the interpretation of historical drilling, geophysical, geochemical and geological data, including the significance of historical uranium intersections as a foundation for additional exploration; the interpretation of gravity low anomalies as possible zones of hydrothermal alteration and potential fluid pathways, and the prioritization of drill targets based on such interpretation; the expectation that the shallow depth of sandstone cover will allow multiple targets to be tested with relatively few metres of drilling; the potential for further exploration along the conductive corridor at Turkey Lake; the completion of the transaction with Denison announced on October 22, 2026 and the Company’s ability to increase its interest in the properties under option from Denison; and the long-term growth in demand expected for carbon-free energy sources.

In making the forward-looking statements in this news release, the Company has applied several material assumptions, including, without limitation, that: the Company’s interpretation of historical drilling, geophysical, geochemical and geological data, including the data from the ground gravity survey completed in January 2026, is accurate; historical drilling results and other historical data are reliable and indicative of the potential for uranium mineralization at Turkey Lake; the drill program will be carried out as planned, within the anticipated budget and timeframe, and will test the targets currently identified; drilling equipment, contractors, supplies and qualified personnel will be available as required; the transaction with Denison will be completed on the terms and within the timeframes currently anticipated; the Company will have access to sufficient capital, on acceptable terms, to fund its exploration programs and to satisfy the requirements to increase its interest in the properties under option from Denison; all required permits and approvals will be obtained, and any required consultation with Indigenous communities will be completed, in a timely manner; there will be no material adverse change in uranium prices, general economic, market or industry conditions; and exploration and permitting activities will not be materially delayed by weather, regulatory or other factors.

Forward-looking information is subject to certain risks, trends and uncertainties that could cause actual results to differ materially from those projected. Many of these factors are beyond the Company’s ability to control or predict. Important factors that may cause actual results to differ materially and that could impact the Company and the statements contained in this news release include, among others: the inherent uncertainty of mineral exploration and the speculative nature of exploration-stage properties; the risk that the drill program does not intersect uranium mineralization or that exploration does not result in the discovery or delineation of a mineral resource; the risk that historical drilling results and other historical data are inaccurate, incomplete or not indicative of mineralization at Turkey Lake; uncertainties in the interpretation of geological and geophysical data, including the risk that gravity low anomalies do not reflect hydrothermal alteration or structures capable of hosting uranium mineralization; the risk that the drill program is delayed, reduced in scope or does not test the planned number of targets; the availability of drilling equipment, contractors, supplies and qualified personnel; the risk that the transaction with Denison is not completed on the anticipated terms or timeline, or at all; the Company’s inability to complete the expenditures and other requirements to increase its interest in the properties under option from Denison; the availability of capital to fund programs and the resulting dilution caused by the raising of capital through the sale of shares; continuity of agreements with third parties, including Denison; fluctuations in uranium and other commodity prices and in the market price of the Company’s common shares; risks and uncertainties associated with the environment; and delays in obtaining governmental approvals, permits or financing.

Additional factors that may cause actual results to differ materially and that could impact the Company and the statements contained in this news release can be found in the Company’s filings with the Securities and Exchange Commission. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Although the Company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, it can give no assurance that its expectations will be achieved. The Company assumes no obligation to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Accordingly, readers should not place undue reliance on forward-looking statements contained in this news release and in any document referred to in this news release. This news release shall not constitute an offer to sell or the solicitation of an offer to buy securities. Please refer to the Company’s most recent filings under its profile on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov for further information respecting the risks affecting the Company and its business.

The CSE has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.

^{__________________________
i} Saskatchewan Mineral Assessment File 64L05-0037
ⁱⁱ Saskatchewan Mineral Assessment File 64L12-0077

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/2b9204aa-9323-4a54-b77a-bc290813bd57

https://www.globenewswire.com/NewsRoom/AttachmentNg/c9407021-6c63-4e0f-96de-85529060a703

Company announcement
No. 71/2026

2 November 2026

Major shareholder announcement

Netcompany Group A/S (“Netcompany”) hereby announces the following notification received pursuant to section 38 of the Danish Capital Markets Act from Handelsbanken Fonder AB (“Handelsbanken”), regarding their direct holdings and voting rights in Netcompany.

On 30 October 2026 Handelsbanken informed Netcompany, that Handelsbanken on 29 October 2026 directly controlled 2,361,523 voting rights corresponding to 5.13% of the total voting rights in Netcompany.

This announcement is in accordance with section 30 of the Danish Capital Markets Act.

For further information, please see the attached notification form.

Additional information
For additional information, please contact:

Netcompany Group A/S
Thomas Johansen, CFO, +45 51 19 32 24
Frederikke Linde, Head of IR, +45 60 62 60 87

Attachments

• 71. Netcompany – Major shareholder announcement – Handelsbanken
• 71. Notification Handelsbanken

Company announcement
No. 71/2026

2 November 2026

Major shareholder announcement

Netcompany Group A/S (“Netcompany”) hereby announces the following notification received pursuant to section 38 of the Danish Capital Markets Act from Handelsbanken Fonder AB (“Handelsbanken”), regarding their direct holdings and voting rights in Netcompany.

On 30 October 2026 Handelsbanken informed Netcompany, that Handelsbanken on 29 October 2026 directly controlled 2,361,523 voting rights corresponding to 5.13% of the total voting rights in Netcompany.

This announcement is in accordance with section 30 of the Danish Capital Markets Act.

For further information, please see the attached notification form.

Additional information
For additional information, please contact:

Netcompany Group A/S
Thomas Johansen, CFO, +45 51 19 32 24
Frederikke Linde, Head of IR, +45 60 62 60 87

Attachments

• 71. Netcompany – Major shareholder announcement – Handelsbanken
• 71. Notification Handelsbanken

Toronto, Ontario, Nov. 02, 2026 (GLOBE NEWSWIRE) — Atlas One Capital Corporation (TSXV: ACAP.P) (the “Corporation” or “Atlas One”), a capital pool company listed on the TSX Venture Exchange (“TSXV”), and Ramsden Metals Inc. (“Ramsden Metals” and, together with Atlas One, the “Parties”) are pleased to provide an update on their proposed business combination transaction (the “Proposed Transaction”) as previously announced on July 14, 2026. It is anticipated that the Proposed Transaction will constitute the qualifying transaction of Atlas One in accordance with Policy 2.4 – Capital Pool Companies of the Corporate Finance Manual (the “CPC Policy”) of the TSXV. The resulting company following the completion of the Proposed Transaction is referred to as the “Resulting Issuer”. All currency references used in this news release are in Canadian currency unless otherwise noted.

Definitive Agreement

The Parties are pleased to announce that they have entered into a definitive agreement dated October 30, 2026 (the “Definitive Agreement”) pursuant to which Atlas One will acquire all of the issued and outstanding securities of Ramsden Metals in exchange for the issuance of securities of Atlas One. As consideration for the acquisition of all of the outstanding common shares of Ramsden Metals (“Ramsden Shares”), holders of Ramsden Shares will receive one (1) post-Consolidation (as defined below) common share of Atlas One (each, a “Resulting Issuer Share”) for each one (1) Ramsden Share held at the time of the completion of the Proposed Transaction.

The Proposed Transaction will be completed by way of a three-cornered amalgamation among Atlas One, Ramsden Metals, and a wholly owned subsidiary of Atlas One, to be incorporated in the Province of Ontario by Atlas One, which will amalgamate (the “Amalgamation”) with Ramsden Metals (the amalgamated company shall hereinafter be referred to as “Amalco”). Pursuant to the Amalgamation, Atlas One shall acquire all of the issued and outstanding Ramsden Shares. The result of the foregoing shall be that, on completion of the Proposed Transaction, Amalco shall be a wholly owned subsidiary of the Resulting Issuer. Upon the completion of the Proposed Transaction, it is expected the Resulting Issuer will change its name to Ramsden Metals Ltd., or such other name as Ramsden Metals may determine (the “Name Change”), and the Resulting Issuer will be a mining issuer focused on exploration of the Eagle’s Nest Critical Metals Project.

Under the terms of the Definitive Agreement, Atlas One shall consolidate (the “Consolidation”) its outstanding common shares (the “Atlas Shares”) on a basis that results in the existing Atlas Shareholders collectively holding that number of post-Consolidation Atlas Shares equal to an agree value of Atlas (fixed at $325,000) divided by the offering price under the Concurrent Offering (as defined below); provided that if the Concurrent Offering is comprised solely of an offering of Ramsden Shares issued on a flow-through basis, the price used to determine the consolidation ratio shall be 70% of the offering price under the Concurrent Offering.

The Parties have agreed that the Proposed Transaction is conditional upon certain conditions precedent, including, but not limited to, the completion of the Concurrent Financing (as defined below), the Consolidation, Name Change and the receipt of all necessary regulatory and shareholder approvals, including the approval of the Amalgamation by the shareholders of Ramsden Metals.

There can be no assurance that the Proposed Transaction will be completed as proposed or at all. Investors are cautioned that, except as disclosed in the filing statement to be prepared in connection with the Proposed Transaction, any information released or received with respect to the Proposed Transaction may not be accurate or complete and should not be relied upon. Trading in the securities of a capital pool company should be considered highly speculative. The TSXV has in no way passed upon the merits of the Proposed Transaction and has neither approved nor disapproved the contents of this news release.

Shareholder Approval

Atlas One shall hold an annual general and special shareholder meeting for the purposes of obtaining shareholder approval for the Name Change and Consolidation. Atlas One will not seek nor is it required to obtain securityholder approval of the Proposed Transaction pursuant to applicable securities laws or the policies of the TSXV. The Proposed Transaction is not a “Non-Arm’s Length Qualifying Transaction” as such term is defined in the CPC Policy. No Non-Arm’s Length Party to Atlas One (as such term is defined in the CPC Policy) (a) has any direct or indirect beneficial interest in Ramsden Metals, or (b) is an insider of Ramsden Metals. There is no relationship between or among a Non-Arm’s Length Party to Atlas One and a Non-Arm’s Length Party to the Qualifying Transaction (as such terms are defined in the CPC Policy).

Concurrent Financing 

The Proposed Transaction remains conditional upon an expected offering (the “Concurrent Financing”) of subscription receipts (the “Subscription Receipts”) by Ramsden Metals on such price, size and other terms as may be determined by Ramsden Metals and accepted by the TSXV, provided that following the Proposed Transaction the funds resulting to the Resulting Issuer are sufficient to satisfy the applicable financing and listing requirements of the TSXV.

It is expected that each Subscription Receipt will represent the right of a holder to receive, upon satisfaction or waiver of certain escrow release conditions, without payment of additional consideration, securities of Ramsden Metals in accordance with the terms and conditions of a subscription receipt agreement (the “Subscription Receipt Agreement”) to be entered into among the Parties and a subscription receipt and escrow agent upon closing of the Concurrent Financing.

Pursuant to the terms of the Proposed Transaction, the Concurrent Financing and the Subscription Receipt Agreement, any Ramsden Share issued upon conversion of the Subscription Receipts would be exchanged for one Resulting Issuer Share and any common share purchase warrant of Ramsden Metals issued upon conversion of the Subscription Receipts would be exchanged for one common share purchase warrant of the Resulting Issuer.

The Parties acknowledge that an agent may be engaged to act as agent on a “commercially reasonable efforts” basis for the Concurrent Financing, or finders may be engaged in connection with the Concurrent Financing, and in connection therewith may be paid a commission in an amount to be determined.

The Parties expect to announce the Concurrent Financing by news release upon launch of the same, and to include additional details and final terms of the Concurrent Financing in such news release.

The Resulting Issuer

The Parties expect that the Resulting Issuer following from the Proposed Transaction will carry on the existing business of Ramsden Metals and be a mineral exploration company focused on exploration of the Eagle’s Nest Critical Metals Project. See “Definitive Agreement” above for details concerning the expected corporate structure of the Resulting Issuer upon completion of the Proposed Transaction.

Trading Halt

The Atlas Shares are currently halted from trading and are not expected to resume trading until the Proposed Transaction is completed.

About Ramsden Metals

Ramsden Metals is a privately held Canadian mineral exploration company focused on identifying, acquiring and advancing critical-mineral opportunities in North America. Ramsden Metals’ principal asset is the Eagle’s Nest Critical Metals Project, an early-stage exploration property comprising approximately 51.25 square kilometres of mineral claims located approximately 125 kilometres north of Churchill Falls in central Labrador. The property is centred on the Michikamats intrusive complex and a prominent circular magnetic anomaly.

Information Concerning Atlas One

Atlas One is a capital pool company and the Atlas One Shares are listed for trading on the TSXV under the symbol “ACAP.P”.

For further information, please contact: 

David Rosenkrantz
President, CEO, CFO and Director at 416-865-0123

Information concerning Ramsden Metals, including the proposed directors of the Resulting Issuer, has been provided to the Corporation by Ramsden Metals for inclusion in this news release. The scientific and technical information concerning the Eagle’s Nest Critical Metals Project contained in this news release has been reviewed and approved by Dr. E. Max Baker, FAusIMM, Senior Geological Advisor to Ramsden Metals and a “qualified person” as defined in National Instrument 43-101 (“NI 43-101”) – Standards of Disclosure for Mineral Projects.

Completion of the Proposed Transaction is subject to a number of conditions, including but not limited to, TSXV acceptance and if applicable pursuant to Exchange Requirements (as that term is defined in the policies of the TSXV), majority of the minority shareholder approval. Where applicable, the Proposed Transaction cannot close until the required shareholder approval is obtained. There can be no assurance that the Proposed Transaction will be completed as proposed or at all.

Investors are cautioned that, except as disclosed in the management information circular or filing statement to be prepared in connection with the Proposed Transaction, any information released or received with respect to the Proposed Transaction may not be accurate or complete and should not be relied upon. Trading in the securities of a capital pool company should be considered highly speculative.

The TSXV has in no way passed upon the merits of the Proposed Transaction and has neither approved nor disapproved the contents of this news release. Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release. 

The securities referenced herein have not been, nor will be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent U.S. registration or an applicable exemption from U.S. registration requirements. This release does not constitute an offer for sale of securities in the United States.

Cautionary and Forward-Looking Statements

This news release contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking statements”) within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes”, “intends” or variations of such words and phrases or stating that certain actions, events or results “may”, “could, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements relate, among other things, to: the Proposed Transaction and certain terms and conditions thereof; the Consolidation; the Name Change; the anticipated listing of the Resulting Issuer on the TSXV; the business of Ramsden Metals; the exploration and advancement of the Eagle’s Nest Critical Metals Project; the Concurrent Financing and the anticipated use of proceeds therefrom; shareholder, director and regulatory approvals; and future news releases and disclosure. Forward looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors that may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; and the delay or failure to receive shareholder, director or regulatory approvals. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. Except as required by law, Atlas One assumes no obligation to update the forward-looking statements or beliefs, opinions, projections, or other factors, should they change.

Toronto, Ontario, Nov. 02, 2026 (GLOBE NEWSWIRE) — Atlas One Capital Corporation (TSXV: ACAP.P) (the “Corporation” or “Atlas One”), a capital pool company listed on the TSX Venture Exchange (“TSXV”), and Ramsden Metals Inc. (“Ramsden Metals” and, together with Atlas One, the “Parties”) are pleased to provide an update on their proposed business combination transaction (the “Proposed Transaction”) as previously announced on July 14, 2026. It is anticipated that the Proposed Transaction will constitute the qualifying transaction of Atlas One in accordance with Policy 2.4 – Capital Pool Companies of the Corporate Finance Manual (the “CPC Policy”) of the TSXV. The resulting company following the completion of the Proposed Transaction is referred to as the “Resulting Issuer”. All currency references used in this news release are in Canadian currency unless otherwise noted.

Definitive Agreement

The Parties are pleased to announce that they have entered into a definitive agreement dated October 30, 2026 (the “Definitive Agreement”) pursuant to which Atlas One will acquire all of the issued and outstanding securities of Ramsden Metals in exchange for the issuance of securities of Atlas One. As consideration for the acquisition of all of the outstanding common shares of Ramsden Metals (“Ramsden Shares”), holders of Ramsden Shares will receive one (1) post-Consolidation (as defined below) common share of Atlas One (each, a “Resulting Issuer Share”) for each one (1) Ramsden Share held at the time of the completion of the Proposed Transaction.

The Proposed Transaction will be completed by way of a three-cornered amalgamation among Atlas One, Ramsden Metals, and a wholly owned subsidiary of Atlas One, to be incorporated in the Province of Ontario by Atlas One, which will amalgamate (the “Amalgamation”) with Ramsden Metals (the amalgamated company shall hereinafter be referred to as “Amalco”). Pursuant to the Amalgamation, Atlas One shall acquire all of the issued and outstanding Ramsden Shares. The result of the foregoing shall be that, on completion of the Proposed Transaction, Amalco shall be a wholly owned subsidiary of the Resulting Issuer. Upon the completion of the Proposed Transaction, it is expected the Resulting Issuer will change its name to Ramsden Metals Ltd., or such other name as Ramsden Metals may determine (the “Name Change”), and the Resulting Issuer will be a mining issuer focused on exploration of the Eagle’s Nest Critical Metals Project.

Under the terms of the Definitive Agreement, Atlas One shall consolidate (the “Consolidation”) its outstanding common shares (the “Atlas Shares”) on a basis that results in the existing Atlas Shareholders collectively holding that number of post-Consolidation Atlas Shares equal to an agree value of Atlas (fixed at $325,000) divided by the offering price under the Concurrent Offering (as defined below); provided that if the Concurrent Offering is comprised solely of an offering of Ramsden Shares issued on a flow-through basis, the price used to determine the consolidation ratio shall be 70% of the offering price under the Concurrent Offering.

The Parties have agreed that the Proposed Transaction is conditional upon certain conditions precedent, including, but not limited to, the completion of the Concurrent Financing (as defined below), the Consolidation, Name Change and the receipt of all necessary regulatory and shareholder approvals, including the approval of the Amalgamation by the shareholders of Ramsden Metals.

There can be no assurance that the Proposed Transaction will be completed as proposed or at all. Investors are cautioned that, except as disclosed in the filing statement to be prepared in connection with the Proposed Transaction, any information released or received with respect to the Proposed Transaction may not be accurate or complete and should not be relied upon. Trading in the securities of a capital pool company should be considered highly speculative. The TSXV has in no way passed upon the merits of the Proposed Transaction and has neither approved nor disapproved the contents of this news release.

Shareholder Approval

Atlas One shall hold an annual general and special shareholder meeting for the purposes of obtaining shareholder approval for the Name Change and Consolidation. Atlas One will not seek nor is it required to obtain securityholder approval of the Proposed Transaction pursuant to applicable securities laws or the policies of the TSXV. The Proposed Transaction is not a “Non-Arm’s Length Qualifying Transaction” as such term is defined in the CPC Policy. No Non-Arm’s Length Party to Atlas One (as such term is defined in the CPC Policy) (a) has any direct or indirect beneficial interest in Ramsden Metals, or (b) is an insider of Ramsden Metals. There is no relationship between or among a Non-Arm’s Length Party to Atlas One and a Non-Arm’s Length Party to the Qualifying Transaction (as such terms are defined in the CPC Policy).

Concurrent Financing 

The Proposed Transaction remains conditional upon an expected offering (the “Concurrent Financing”) of subscription receipts (the “Subscription Receipts”) by Ramsden Metals on such price, size and other terms as may be determined by Ramsden Metals and accepted by the TSXV, provided that following the Proposed Transaction the funds resulting to the Resulting Issuer are sufficient to satisfy the applicable financing and listing requirements of the TSXV.

It is expected that each Subscription Receipt will represent the right of a holder to receive, upon satisfaction or waiver of certain escrow release conditions, without payment of additional consideration, securities of Ramsden Metals in accordance with the terms and conditions of a subscription receipt agreement (the “Subscription Receipt Agreement”) to be entered into among the Parties and a subscription receipt and escrow agent upon closing of the Concurrent Financing.

Pursuant to the terms of the Proposed Transaction, the Concurrent Financing and the Subscription Receipt Agreement, any Ramsden Share issued upon conversion of the Subscription Receipts would be exchanged for one Resulting Issuer Share and any common share purchase warrant of Ramsden Metals issued upon conversion of the Subscription Receipts would be exchanged for one common share purchase warrant of the Resulting Issuer.

The Parties acknowledge that an agent may be engaged to act as agent on a “commercially reasonable efforts” basis for the Concurrent Financing, or finders may be engaged in connection with the Concurrent Financing, and in connection therewith may be paid a commission in an amount to be determined.

The Parties expect to announce the Concurrent Financing by news release upon launch of the same, and to include additional details and final terms of the Concurrent Financing in such news release.

The Resulting Issuer

The Parties expect that the Resulting Issuer following from the Proposed Transaction will carry on the existing business of Ramsden Metals and be a mineral exploration company focused on exploration of the Eagle’s Nest Critical Metals Project. See “Definitive Agreement” above for details concerning the expected corporate structure of the Resulting Issuer upon completion of the Proposed Transaction.

Trading Halt

The Atlas Shares are currently halted from trading and are not expected to resume trading until the Proposed Transaction is completed.

About Ramsden Metals

Ramsden Metals is a privately held Canadian mineral exploration company focused on identifying, acquiring and advancing critical-mineral opportunities in North America. Ramsden Metals’ principal asset is the Eagle’s Nest Critical Metals Project, an early-stage exploration property comprising approximately 51.25 square kilometres of mineral claims located approximately 125 kilometres north of Churchill Falls in central Labrador. The property is centred on the Michikamats intrusive complex and a prominent circular magnetic anomaly.

Information Concerning Atlas One

Atlas One is a capital pool company and the Atlas One Shares are listed for trading on the TSXV under the symbol “ACAP.P”.

For further information, please contact: 

David Rosenkrantz
President, CEO, CFO and Director at 416-865-0123

Information concerning Ramsden Metals, including the proposed directors of the Resulting Issuer, has been provided to the Corporation by Ramsden Metals for inclusion in this news release. The scientific and technical information concerning the Eagle’s Nest Critical Metals Project contained in this news release has been reviewed and approved by Dr. E. Max Baker, FAusIMM, Senior Geological Advisor to Ramsden Metals and a “qualified person” as defined in National Instrument 43-101 (“NI 43-101”) – Standards of Disclosure for Mineral Projects.

Completion of the Proposed Transaction is subject to a number of conditions, including but not limited to, TSXV acceptance and if applicable pursuant to Exchange Requirements (as that term is defined in the policies of the TSXV), majority of the minority shareholder approval. Where applicable, the Proposed Transaction cannot close until the required shareholder approval is obtained. There can be no assurance that the Proposed Transaction will be completed as proposed or at all.

Investors are cautioned that, except as disclosed in the management information circular or filing statement to be prepared in connection with the Proposed Transaction, any information released or received with respect to the Proposed Transaction may not be accurate or complete and should not be relied upon. Trading in the securities of a capital pool company should be considered highly speculative.

The TSXV has in no way passed upon the merits of the Proposed Transaction and has neither approved nor disapproved the contents of this news release. Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release. 

The securities referenced herein have not been, nor will be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent U.S. registration or an applicable exemption from U.S. registration requirements. This release does not constitute an offer for sale of securities in the United States.

Cautionary and Forward-Looking Statements

This news release contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking statements”) within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes”, “intends” or variations of such words and phrases or stating that certain actions, events or results “may”, “could, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements relate, among other things, to: the Proposed Transaction and certain terms and conditions thereof; the Consolidation; the Name Change; the anticipated listing of the Resulting Issuer on the TSXV; the business of Ramsden Metals; the exploration and advancement of the Eagle’s Nest Critical Metals Project; the Concurrent Financing and the anticipated use of proceeds therefrom; shareholder, director and regulatory approvals; and future news releases and disclosure. Forward looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors that may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; and the delay or failure to receive shareholder, director or regulatory approvals. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. Except as required by law, Atlas One assumes no obligation to update the forward-looking statements or beliefs, opinions, projections, or other factors, should they change.

YYForce presents its reported book equity alongside its market capitalization to give investors additional context for its growth plans

SINGAPORE, Nov. 02, 2026 (GLOBE NEWSWIRE) — YYForce Inc. (Nasdaq: YFOR) (“YYForce” or the “Company”), a technology-enabled provider of workforce solutions and integrated facility management services, today highlighted its reported net assets of approximately US$21.9 million, compared with an estimated market capitalization of approximately US$2.1 million as of October 30, 2026, and outlined its commercial robotics and AI priorities.

YYForce is providing this information to help investors evaluate its reported asset base alongside its operating results, liquidity and strategy across workforce platforms, integrated facility management and service robotics.

Reported financial position and valuation comparison

As reported in the Company’s Form 6-K filed on September 25, 2026, YYForce’s consolidated balance sheet as of June 30, 2026, showed the following amounts.

Balance sheet measure	Reported amount
Total assets	Approximately US$38 million
Equity attributable to YYForce shareholders (net assets)	Approximately US$21.9 million

As of October 30, 2026, the Company’s estimated equity market capitalization was approximately US$2.1 million, equivalent to approximately 9.6% of reported equity attributable to YYForce shareholders. This represented a discount of approximately 90.4% to reported book equity. This information uses rounded amounts and reflects financial and market data from different dates.

Book equity does not represent unrestricted cash, tangible net assets, liquidation proceeds or an estimate of intrinsic value. Asset carrying values are subject to accounting estimates and impairment assessments. Investors should consider the full financial statements, including liabilities, operating results, cash flows and subsequent disclosures.

Management commentary

“We believe the difference between our reported book equity and public market capitalization warrants investors’ attention,” said Mike Fu, Chief Executive Officer of YYForce. “Our responsibility is to provide clear financial information and execute our commercial strategy. We remain focused on customer delivery, disciplined capital allocation and developing our workforce, facility management and service robotics businesses.”

“We will evaluate each investment against customer demand, available liquidity, capital requirements and expected returns,” Mr. Fu added.

Strategic growth priorities

Commercial robotics expansion. Pursuing service robotics deployments and integration with hospitality and enterprise workflows, with attention to customer requirements, deployment costs and ongoing support.

AI-enabled facility and workforce platforms. Developing digital platform capabilities and pursuing enterprise adoption to support workforce coordination, shift delivery and facility operations.

Capital discipline and market transparency. Evaluating commercial deployments against customer demand, capital requirements and expected returns, while providing shareholders with clear updates on material developments.

YYForce will continue to assess its operating performance, financing requirements and capital allocation priorities as its business develops. Future commercial progress remains subject to operational execution, customer adoption and broader market conditions.

About YYForce Inc.

YYForce Inc. (Nasdaq: YFOR) is a technology-enabled provider of workforce solutions and integrated facility management services. The Company is developing AI-enabled workforce platforms and robotics capabilities to support frontline operations, improve productivity and address evolving customer needs.

For more information, visit www.yyforce.ai.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements are based on the Company’s current expectations, assumptions and information available to it as of the date of this release. Forward-looking statements can be identified by words such as “may,” “will,” “should,” “expects,” “anticipates,” “plans,” “intends,” “believes,” “estimates,” “potential” or similar expressions, or the negative of these terms.

Forward-looking statements in this release include, but are not limited to, expectations regarding the Company’s strategy, commercial deployments, platform development, operational efficiency, capital allocation and future business performance. Historical financial figures are not forward-looking statements. Reported book equity is not an indication of the price at which the Company’s shares may trade or of amounts that would be realized on any sale or liquidation.

Forward-looking statements involve inherent risks and uncertainties, and the forward-looking events discussed in this press release may not occur, actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about the Company and a number of factors. For a more detailed discussion of risk factors, please refer to the Company’s filings with the U.S. Securities and Exchange Commission, including the “Risk Factors” section of the Company’s most recent annual report on Form 20-F, as amended. YYForce undertakes no obligation to update these statements except as required by applicable law.

Investor Relations Contact

YYForce Inc.
Investor Relations Department
Email: ir@yyforce.ai
Website: www.yyforce.ai

YYForce presents its reported book equity alongside its market capitalization to give investors additional context for its growth plans

SINGAPORE, Nov. 02, 2026 (GLOBE NEWSWIRE) — YYForce Inc. (Nasdaq: YFOR) (“YYForce” or the “Company”), a technology-enabled provider of workforce solutions and integrated facility management services, today highlighted its reported net assets of approximately US$21.9 million, compared with an estimated market capitalization of approximately US$2.1 million as of October 30, 2026, and outlined its commercial robotics and AI priorities.

YYForce is providing this information to help investors evaluate its reported asset base alongside its operating results, liquidity and strategy across workforce platforms, integrated facility management and service robotics.

Reported financial position and valuation comparison

As reported in the Company’s Form 6-K filed on September 25, 2026, YYForce’s consolidated balance sheet as of June 30, 2026, showed the following amounts.

Balance sheet measure	Reported amount
Total assets	Approximately US$38 million
Equity attributable to YYForce shareholders (net assets)	Approximately US$21.9 million

As of October 30, 2026, the Company’s estimated equity market capitalization was approximately US$2.1 million, equivalent to approximately 9.6% of reported equity attributable to YYForce shareholders. This represented a discount of approximately 90.4% to reported book equity. This information uses rounded amounts and reflects financial and market data from different dates.

Book equity does not represent unrestricted cash, tangible net assets, liquidation proceeds or an estimate of intrinsic value. Asset carrying values are subject to accounting estimates and impairment assessments. Investors should consider the full financial statements, including liabilities, operating results, cash flows and subsequent disclosures.

Management commentary

“We believe the difference between our reported book equity and public market capitalization warrants investors’ attention,” said Mike Fu, Chief Executive Officer of YYForce. “Our responsibility is to provide clear financial information and execute our commercial strategy. We remain focused on customer delivery, disciplined capital allocation and developing our workforce, facility management and service robotics businesses.”

“We will evaluate each investment against customer demand, available liquidity, capital requirements and expected returns,” Mr. Fu added.

Strategic growth priorities

Commercial robotics expansion. Pursuing service robotics deployments and integration with hospitality and enterprise workflows, with attention to customer requirements, deployment costs and ongoing support.

AI-enabled facility and workforce platforms. Developing digital platform capabilities and pursuing enterprise adoption to support workforce coordination, shift delivery and facility operations.

Capital discipline and market transparency. Evaluating commercial deployments against customer demand, capital requirements and expected returns, while providing shareholders with clear updates on material developments.

YYForce will continue to assess its operating performance, financing requirements and capital allocation priorities as its business develops. Future commercial progress remains subject to operational execution, customer adoption and broader market conditions.

About YYForce Inc.

YYForce Inc. (Nasdaq: YFOR) is a technology-enabled provider of workforce solutions and integrated facility management services. The Company is developing AI-enabled workforce platforms and robotics capabilities to support frontline operations, improve productivity and address evolving customer needs.

For more information, visit www.yyforce.ai.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements are based on the Company’s current expectations, assumptions and information available to it as of the date of this release. Forward-looking statements can be identified by words such as “may,” “will,” “should,” “expects,” “anticipates,” “plans,” “intends,” “believes,” “estimates,” “potential” or similar expressions, or the negative of these terms.

Forward-looking statements in this release include, but are not limited to, expectations regarding the Company’s strategy, commercial deployments, platform development, operational efficiency, capital allocation and future business performance. Historical financial figures are not forward-looking statements. Reported book equity is not an indication of the price at which the Company’s shares may trade or of amounts that would be realized on any sale or liquidation.

Forward-looking statements involve inherent risks and uncertainties, and the forward-looking events discussed in this press release may not occur, actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about the Company and a number of factors. For a more detailed discussion of risk factors, please refer to the Company’s filings with the U.S. Securities and Exchange Commission, including the “Risk Factors” section of the Company’s most recent annual report on Form 20-F, as amended. YYForce undertakes no obligation to update these statements except as required by applicable law.

Investor Relations Contact

YYForce Inc.
Investor Relations Department
Email: ir@yyforce.ai
Website: www.yyforce.ai